Additional prognostic value of second-trimester biomarker measurement for predicting preeclampsia before 37 weeks in a Russian cohort
Ivshin A.A., Boldina Yu.S., Malyshev N.A.
Objective: To assess the additional prognostic value of second-trimester biomarker measurements (MAP, UtAPI, PlGF) for predicting preeclampsia before 37 weeks (pPE) and to compare the discrimination, calibration, and clinical utility of a machine learning (ML) logistic regression model and the Fetal Medicine Foundation (FMF) Bayesian algorithm.
Materials and methods: A multicenter retrospective cohort study was conducted using the MARS register of pregnant women (development cohort: 7,101 singleton pregnancies, 133 pPE cases; external validation: 1,325 pregnancies, 24 pPE cases). First-trimester (M2:15 maternal factors + 3 biomarkers) and combined first- and second-trimester (M4: M2 + 3 second-trimester biomarkers) ML models were developed and compared with FMF algorithms (T1, T2). The AUC, calibration (O:E ratio), NRI, IDI, decision curve analysis, and reclassification safety were evaluated.
Results: Second-trimester biomarkers significantly improved discrimination: ΔAUC +0.025 (p=0.001) for ML and +0.031 (p<0.001) for FMF. ML M4 and FMF T2 showed equivalent discrimination (AUC 0.927 vs. 0.935; p=0.91), but ML M4 demonstrated superior calibration (O:E 1.00 vs. 0.81). The detection rates at the 1:100 threshold were 89.5% (ML M4) and 88.0% (FMF T2). Over 99% of the risk downgrades were correct. External validation: AUC of 0.897 (ML M4) and 0.905 (FMF T2).
Conclusion: Additional second-trimester biomarker measurements significantly improved pPE prediction. ML and FMF achieved equivalent discrimination, but ML provided superior calibration in a Russian cohort, supporting the prospective evaluation of a two-stage prenatal pPE screening protocol.
Authors' contributions: Ivshin A.A. – conception and supervision of the study, expert analysis of results, editing of the manuscript; Boldina Yu.S. – drafting of the manuscript; Malyshev N.A. – data analysis and mathematical modeling.
Conflicts of interest: The authors have no conflicts of interest to declare.
Funding: The study was financially supported by the Russian Science Foundation No 24-25-00429,
https://rscf.ru/project/24-25-00429/
Ethical Approval: The study was reviewed and approved by the Research Ethics Committee of the Petrozavodsk State University (Ref. No: 18 of 20.03.2024).
Acknowledgements: The authors express their gratitude to Professor Zulfiya S. Khodjaeva, MD, PhD, Deputy Director for Research at the Institute of Obstetrics, V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Moscow, Russia, for her foundational research on the heterogeneity of preeclampsia, which shaped the theoretical framework of the present study, and for her pioneering work on the validation of preeclampsia prediction algorithms in the Russian population, which served as the starting point and methodological reference for this research.
AI disclosure: The Claude 3.5 Sonnet model (Anthropic) was used to reduce the length of this article through editorial and stylistic editing. The resulting content was then reviewed, edited and approved by the authors. The authors bear full responsibility for the accuracy of the publication's content.
Authors' Data Sharing Statement: De-identified data used in this study are available upon reasonable request, in accordance with the requirements of Federal Law No. 152-FZ 'On Personal Data'. Requests should be directed to the corresponding author (scipeople@mail.ru).
For citation: Ivshin A.A., Boldina Yu.S., Malyshev N.A. Additional prognostic value of second-trimester biomarker measurement for predicting preeclampsia before 37 weeks in a Russian cohort.
Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2026; (4): 96-104 (in Russian)
https://dx.doi.org/10.18565/aig.2026.51
Keywords
References
- Brown M.A., Magee L.A., Kenny L.C., Karumanchi S.A., McCarthy F.P., Saito S. et al. The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens. 2018; 13: 291-310. https://dx.doi.org/10.1016/j.preghy.2018.05.004
- Ходжаева З.С., Холин А.М., Вихляева Е.М. Ранняя и поздняя преэклампсия: парадигмы патобиологии и клиническая практика. Акушерство и гинекология. 2013; 10: 4-11. [Khodzhaeva Z.S., Kholin A.M., Vikhlyaeva E.M. Early and late preeclampsia: paradigms of pathobiology and clinical practice. Obstetrics and Gynecology. 2013; (10): 4-11 (in Russian)].
- Министерство здравоохранения Российской Федерации. Клинические рекомендации. Преэклампсия. Эклампсия. Отеки, протеинурия и гипертензивные расстройства во время беременности, в родах и послеродовом периоде. 2024. [Ministry of Health of the Russian Federation. Clinical guidelines. Preeclampsia. Eclampsia. Edema, proteinuria and hypertensive disorders during pregnancy, labor and the postpartum period. 2024 (in Russian)].
- Кан Н.Е., Беднягин Л.А., Долгушина Н.В., Тютюнник В.Л., Ховхаева П.А., Сергунина О.А., Тютюнник Н.В., Амирасланов Э.Ю. Клинико-анамнестические факторы риска развития преэклампсии у беременных. Акушерство и гинекология. 2016; 6: 39-44. [Kan N.E., Bednyagin L.A., Dolgushina N.V., Tyutyunnik V.L., Khovkhaeva P.A., Sergunina O.A., Tyutyunnik N.V., Amiraslanov E.Yu. Clinical and anamnestic risk factors for preeclampsia in pregnant women. Obstetrics and Gynecology. 2016; (6): 39-44. (in Russian)]. https://dx.doi.org/10.18565/aig.2016.6.39-44
- Rolnik D.L., Wright D., Poon L.C., O'Gorman N., Syngelaki A., de Paco Matallana C. et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N. Engl. J. Med. 2017; 377(7): 613-22. https://dx.doi.org/10.1056/NEJMoa1704559
- Roberge S., Nicolaides K., Demers S., Hyett J., Chaillet N., Bujold E. The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis. Am. J. Obstet. Gynecol. 2017; 216(2): 110-20.e6. https://dx.doi.org/10.1016/j.ajog.2016.09.076
- Wright D., Akolekar R., Syngelaki A., Poon L.C., Nicolaides K.H. A competing risks model in early screening for preeclampsia. Fetal Diagn. Ther. 2012; 32(3): 171-8. https://dx.doi.org/10.1159/000338470
- O'Gorman N., Wright D., Syngelaki A., Akolekar R., Wright A., Poon L.C. et al. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11–13 weeks gestation. Am. J. Obstet. Gynecol. 2016; 214(1):103.e1-e12. https://dx.doi.org/10.1016/j.ajog.2015.08.034
- Wright D., Tan M.Y., O'Gorman N., Poon L.C., Syngelaki A., Wright A. et al. Predictive performance of the competing risk model in screening for preeclampsia. Am. J. Obstet. Gynecol. 2019; 220(2): 199.e1-e13. https://doi.org/10.1016/j.ajog.2018.11.1087
- Poon L.C., Shennan A., Hyett J.A., Kapur A., Hadar E., Divakar H. et al. The International federation of gynecology and obstetrics (FIGO) initiative on pre-eclampsia: a pragmatic guide for first-trimester screening and prevention. Int. J. Gynaecol. Obstet. 2019; 145(Suppl. 1): 1-33. https://dx.doi.org/10.1002/ijgo.12802
- Tiruneh S.A., Vu T.T.T., Moran L.J., Callander E.J., Allotey J., Thangaratinam S. et al. Externally validated prediction models for pre-eclampsia: systematic review and meta-analysis. Ultrasound Obstet. Gynecol. 2024; 63(5): 592-604. https://dx.doi.org/10.1002/uog.27490
- Холин А.М., Муминова К.Т., Балашов И.С., Ходжаева З.С., Боровиков П.И., Иванец Т.Ю., Гус А.И. Прогнозирование преэклампсии в первом триместре беременности: валидация алгоритмов скрининга на российской популяции. Акушерство и гинекология. 2017; 8: 74-84. [Kholin A.M., Muminova K.T., Balashov I.S., Khodzhaeva Z.S., Borovikov P.I., Ivanets T.Yu., Gus A.I. First-trimester prediction of preeclampsia: Validation of screening algorithms in a Russian population. Obstetrics and Gynecology. 2017; (8): 74-84 (in Russian)]. https://dx.doi.org/10.18565/aig.2017.8.74-84
- Ranjbar A., Montazeri F., Ghamsari S.R., Mehrnoush V., Roozbeh N. Machine learning models for predicting preeclampsia: a systematic review. BMC Pregnancy Childbirth. 2024; 24(1): 6. https://dx.doi.org/10.1186/s12884-023-06220-1
- Андрейченко А.Е., Лучинин А.С., Ившин А.А., Ермак А.Д., Новицкий Р.Э., Гусев А.В. Разработка и валидация моделей прогнозирования общего риска преэклампсии и риска ранней преэклампсии с использованием алгоритмов машинного обучения в первом триместре беременности. Акушерство и гинекология. 2023; 10: 94-107. [Andreychenko A.E., Luchinin A.S., Ivshin A.A., Ermak A.D., Novitskiy R.E., Gusev A.V. Development and validation of models to predict total and early-onset preeclampsia in the first trimester of pregnancy using machine learning algorithms. Obstetrics and Gynecology. 2023; (10): 94-107 (in Russian)]. https://dx.doi.org/10.18565/aig.2023.101
- Ившин А.А., Малышев Н.А. Ранняя стратификация риска преэклампсии на основе мультипараметрической модели машинного обучения и рутинных клинических данных. Акушерство, гинекология и репродукция. 2026; 20(1): 111-29. [Ivshin A.A., Malyshev N.A. Early preeclampsia risk stratification based on a multiparametric machine learning model and routine clinical data. Obstetrics, Gynecology and Reproduction. 2026; 20(1): 111-29 (in Russian)]. https://dx.doi.org/10.17749/2313-7347/ob.gyn.rep.2025.706
- Ходжаева З.С., Коган Е.А., Клименченко Н.И., Акатьева А.С., Сафонова А.Д., Холин А.М., Вавина О.В., Сухих Г.Т. Клинико-патогенетические особенности ранней и поздней преэклампсии. Акушерство и гинекология. 2015; 1: 12-7. [Khodzhaeva Z.S., Kogan E.A., Klimenchenko N.I., Akatyeva A.S., Kholin A.M., Vavina O.V., Sukhikh G.T. Clinical and pathogenetic features of early and late preeclampsia. Obstetrics and Gynecology. 2015; (1): 12-7 (in Russian)].
- Gallo D.M., Wright D., Casanova C., Campanero M., Nicolaides K.H. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 19–24 weeks' gestation. Am. J. Obstet. Gynecol. 2016; 214(5): 619.e1-e17. https://dx.doi.org/10.1016/j.ajog.2015.11.016
- Collins G.S., Reitsma J.B., Altman D.G., Moons K.G. Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): the TRIPOD statement Ann. Intern. Med. 2015; 162(1): 55-63. https://dx.doi.org/10.7326/M14-0697
- Wright D., Syngelaki A., Akolekar R., Poon L.C., Nicolaides K.H. Competing risks model in screening for preeclampsia by maternal characteristics and medical history. Am. J. Obstet. Gynecol. 2015; 213(1): 62.e1-e10. https://dx.doi.org/10.1016/j.ajog.2015.02.018
- Riley R.D., Ensor J., Snell K.I.E., Harrell F.E., Martin G.P., Reitsma J.B. et al. Calculating the sample size required for developing a clinical prediction model. BMJ. 2020; 368: m441. https://dx.doi.org/10.1136/bmj.m441
- Van Calster B., McLernon D.J., van Smeden M., Bottolo L., Timmerman D., Steyerberg E.W. Calibration: the Achilles heel of predictive analytics. BMC Med. 2019; 17(1): 230. https://dx.doi.org/10.1186/s12916-019-1466-7
- Pencina M.J., D'Agostino R.B. Sr., D'Agostino R.B. Jr., Vasan R.S. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat. Med. 2008; 27(2): 157-72. https://dx.doi.org/10.1002/sim.2929
- Vickers A.J., Elkin E.B. Decision curve analysis: a novel method for evaluating prediction models. Med. Decis. Making. 2006; 26(6): 565-74. https://dx.doi.org/10.1177/0272989X06295361
- Riishede L., Wright A., Wright D., Petersen O.B., Nicolaides K.H. Evaluation of second-trimester screening for preterm pre-eclampsia by maternal factors and biomarkers in a Danish population: the PRESIDE study. Ultrasound Obstet. Gynecol. 2023; 62(5): 651-8. https://dx.doi.org/10.1002/uog.26274
- Холин А.М., Ходжаева З.С., Гус А.И. Патологическая плацентация и прогнозирование преэклампсии и задержки роста плода в первом триместре. Акушерство и гинекология. 2018; 5: 12-9. [Kholin A.M., Khodzhaeva Z.S., Gus A.I. Pathological placentation and prediction of preeclampsia and intrauterine growth restriction in the first trimester. Obstetrics and Gynecology. 2018; (5): 12-9 (in Russian)]. https://dx.doi.org/10.18565/aig.2018.5.12-19
- Ившин А.А., Багаудин Т.З., Гусев А.В. Прогнозирование преэклампсии с использованием технологий искусственного интеллекта. Акушерство, гинекология и репродукция. 2021; 15(5): 576-85. [Ivshin A.A., Bagaudin T.Z., Gusev A.V. Prediction of preeclampsia using artificial intelligence technologies. Obstetrics, Gynecology and Reproduction. 2021; 15(5): 576-85 (in Russian)]. https://dx.doi.org/10.17749/2313-7347/ob.gyn.rep.2021.229
- Ivshin A.A., Boldina Yu.S., Gusev A.V., Shtykov A.S., Vasilev A.S. Artificial intelligence on guard of reproductive health. Ad Alta, Journal of Interdisciplinary Research. 2022; 12(02): 325-9. https://dx.doi.org/10.33543/1202
Received 03.02.2026
Accepted 31.03.2026
About the Authors
Aleksandr A. Ivshin, PhD, Associate Professor, Head of the Department of Obstetrics and Gynecology, Dermatovenerology of the Medical Institute, Petrozavodsk State University, 31, Krasnoarmeyskaya str., Petrozavodsk, Republic of Karelia, 185035, Russia, +7(909)567-12-51, scipeople@mail.ru, https://orcid.org/0000-0001-7834-096XYuliya S. Boldina, Senior Lecturer at the Department of Obstetrics, Gynecology, Dermatovenereology of the Medical Institute, Petrozavodsk State University, 31, Krasnoarmeyskaya str., Petrozavodsk, Republic of Karelia, 185035, Russia; Obstetrician-Gynecologist, Republican Perinatal Center named after K.A. Gutkin, Petrozavodsk, +7(981)405-85-24, ulia.isakova94@gmail.com, https://orcid.org/0000-0002-1450-650X
Nikita A. Malyshev, PhD Student in the scientific specialty «Information-Measuring and Control Systems», Lecturer, Department of Family Medicine, Public Health, Healthcare Management, Life Safety, Disaster Medicine, Petrozavodsk State University, 31, Krasnoarmeyskaya str., Petrozavodsk, Republic of Karelia, 185035, Russia, +7(921)461-38-60, malyshev.nikita.2016@gmail.com, https://orcid.org/0009-0005-2722-5976
Corresponding author: Alexander A. Ivshin, scipeople@mail.ru



